(R)-Fenchone; L-(-)-Fenchone; L-Fenchone; l-Fenchone

Details

Top
Internal ID 76fe17e3-1f83-4695-aa92-50d7dc99e3e7
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Monoterpenoids > Bicyclic monoterpenoids
IUPAC Name (1R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-one
SMILES (Canonical) CC1(C2CCC(C2)(C1=O)C)C
SMILES (Isomeric) C[C@@]12CCC(C1)C(C2=O)(C)C
InChI InChI=1S/C10H16O/c1-9(2)7-4-5-10(3,6-7)8(9)11/h7H,4-6H2,1-3H3/t7?,10-/m1/s1
InChI Key LHXDLQBQYFFVNW-OMNKOJBGSA-N
Popularity 3 references in papers

Physical and Chemical Properties

Top
Molecular Formula C10H16O
Molecular Weight 152.23 g/mol
Exact Mass 152.120115130 g/mol
Topological Polar Surface Area (TPSA) 17.10 Ų
XlogP 2.30
Atomic LogP (AlogP) 2.40
H-Bond Acceptor 1
H-Bond Donor 0
Rotatable Bonds 0

Synonyms

Top
SCHEMBL7997210
CHEMBL2269327
(1R)-1,3,3-Trimethylbicyclo[2.2.1]heptane-2-one

2D Structure

Top
2D Structure of (R)-Fenchone; L-(-)-Fenchone; L-Fenchone; l-Fenchone

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9944 99.44%
Caco-2 + 0.8223 82.23%
Blood Brain Barrier + 0.9500 95.00%
Human oral bioavailability + 0.7286 72.86%
Subcellular localzation Lysosomes 0.4838 48.38%
OATP2B1 inhibitior - 0.8428 84.28%
OATP1B1 inhibitior + 0.9479 94.79%
OATP1B3 inhibitior + 0.9617 96.17%
MATE1 inhibitior - 0.8800 88.00%
OCT2 inhibitior - 0.9500 95.00%
BSEP inhibitior - 0.9414 94.14%
P-glycoprotein inhibitior - 0.9822 98.22%
P-glycoprotein substrate - 0.9620 96.20%
CYP3A4 substrate - 0.5182 51.82%
CYP2C9 substrate - 0.7907 79.07%
CYP2D6 substrate - 0.7661 76.61%
CYP3A4 inhibition - 0.9351 93.51%
CYP2C9 inhibition - 0.8596 85.96%
CYP2C19 inhibition - 0.9273 92.73%
CYP2D6 inhibition - 0.9565 95.65%
CYP1A2 inhibition - 0.8062 80.62%
CYP2C8 inhibition - 0.9829 98.29%
CYP inhibitory promiscuity - 0.9511 95.11%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.9100 91.00%
Carcinogenicity (trinary) Non-required 0.5905 59.05%
Eye corrosion - 0.7517 75.17%
Eye irritation + 0.9479 94.79%
Skin irritation + 0.8055 80.55%
Skin corrosion - 0.9398 93.98%
Ames mutagenesis - 0.9500 95.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7667 76.67%
Micronuclear - 0.9800 98.00%
Hepatotoxicity + 0.6302 63.02%
skin sensitisation + 0.9068 90.68%
Respiratory toxicity - 0.5667 56.67%
Reproductive toxicity - 0.5000 50.00%
Mitochondrial toxicity - 0.8164 81.64%
Nephrotoxicity + 0.7185 71.85%
Acute Oral Toxicity (c) IV 0.6235 62.35%
Estrogen receptor binding - 0.9049 90.49%
Androgen receptor binding - 0.8512 85.12%
Thyroid receptor binding - 0.8518 85.18%
Glucocorticoid receptor binding - 0.8885 88.85%
Aromatase binding - 0.8618 86.18%
PPAR gamma - 0.8562 85.62%
Honey bee toxicity - 0.9195 91.95%
Biodegradation + 0.6500 65.00%
Crustacea aquatic toxicity + 0.6800 68.00%
Fish aquatic toxicity + 0.9417 94.17%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 88.24% 97.25%
CHEMBL1937 Q92769 Histone deacetylase 2 87.74% 94.75%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 87.57% 96.09%
CHEMBL3137262 O60341 LSD1/CoREST complex 85.99% 97.09%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 85.16% 94.45%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 85.06% 95.56%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 83.60% 91.11%
CHEMBL4026 P40763 Signal transducer and activator of transcription 3 83.04% 82.69%
CHEMBL1994 P08235 Mineralocorticoid receptor 82.57% 100.00%

Cross-Links

Top
PubChem 2794921
NPASS NPC293343